New developments in treating glycosphingolipid storage diseases.

Podobne zapisy

• Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
  od: Jeyakumar, M, i wsp.
  Wydane: (2002)
• New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
  od: Butters, T, i wsp.
  Wydane: (2003)
• Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
  od: Butters, T, i wsp.
  Wydane: (2000)
• Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
  od: Platt, F, i wsp.
  Wydane: (2000)
• N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
  od: Andersson, U, i wsp.
  Wydane: (2000)